Search Results

October 2022 "G protein-coupled receptors (GPCRs) are of considerable interest due to their importance in a wide range of physiological functions and in a large number of Food and Drug Administration (FDA )-approved drugs as therapeutic entities. signaling effectors: heterotrimeric G proteins, GPCR kinases (GRKs), and β-arrestins. Read more at the source #DrGPCR #GPCR #IndustryNews

GPCR Summit 2022. Mark your calendar for October 10th and 16th. ➡️ https://www.ecosystem.drgpcr.com/ #gpcr #drgpcr

November 2022 "Some G protein-coupled receptor (GPCR) ligands act as "biased agonists" that preferentially Although GPCRs are primarily found at the plasma membrane, GPCRs can traffic to and signal from many is critical to the overall biased response observed at CXCR3, which has important implications for drugs targeting chemokine receptors and other GPCRs." Read more at the source #DrGPCR #GPCR #IndustryNews Subscribe to the Dr. GPCR Newsletter HERE

G protein-coupled receptors (GPCRs) have been shown to play integral roles in Alzheimer's disease pathogenesis However, it is unclear how diverse GPCRs similarly affect Aβ and tau pathogenesis. GPCRs share a common mechanism of action via the β-arrestin scaffolding signaling complexes, which not only serve to desensitize GPCRs by internalization, but also mediate multiple downstream signaling events As signaling via the GPCRs, β2-adrenergic receptor (β2AR), and metabotropic glutamate receptor 2 (mGluR2

➡️ https://bit.ly/3wQNZDg #gpcr #drgpcr

Therapeutics Announces the Formation of a Scientific Advisory Board comprising international leaders in GPCRs pharmacology, immunology, drug discovery and development for auto-immune diseases" Read more at the source #DrGPCR #GPCR #IndustryNews

spotlighting breakthroughs that challenge dogma and deepen our view of receptor dynamics, from the surprising discovery discovery landscape.   drug programs with this four-part course by Dr. Learn the fundamentals of ligand activity, mechanism of action, and GPCR discovery strategy—all at your to power your next discovery.  

Chemokine receptors (CKRs) belong to a subfamily of G-protein-coupled receptors (GPCRs) and play a crucial helix (TM7) near ECL3, while the other links TM3 with ECL2, which is common to the broader class A GPCR Activation in Class A GPCRs Ligand binding in the orthosteric site leads to diverse activation mechanisms In addition, it has a glutamate residue at position 3.45, which is not found in human class A GPCRs, Check the original article at https://pubmed.ncbi.nlm.nih.gov/37212620/ #GPCR #DrGPCR #Ecosystem

ubiquitously expressed membrane proteins that associate with different G protein–coupled receptors (GPCRs ), including the parathyroid hormone 1 receptor (PTH1R), a class B GPCR and an important modulator of These data uncover a critical role of RAMPs in the activation and signaling of a GPCR that may provide a new venue for highly specific modulation of GPCR function and advanced drug design." Read more at the source #DrGPCR #GPCR #IndustryNews

"Fluorescently labeled ligands are versatile molecular tools to study G protein-coupled receptors (GPCRs targeting the intracellular allosteric binding site (IABS) of the CC chemokine receptor 2 (CCR2), a class A GPCR that has been pursued as a drug target in oncology and inflammation. Read more at the source #DrGPCR #GPCR #IndustryNews

September 2022 "G protein-coupled receptors (GPCRs) are signaling hubs in cell membranes that regulate a wide range of physiological processes and are popular drug targets. Serotonin1A receptors are important members of the GPCR family and are implicated in neuropsychiatric To explore the role of cholesterol in lateral dynamics of GPCRs, we utilized single particle tracking Read more at the source #DrGPCR #GPCR #IndustryNews

The awareness of the potential importance of functional selectivity/biased signaling has led to the discovery of biased compounds as both research tools and novel drugs. A major pan-receptor focus has been to identify GPCR-selective ligands that have bias in G protein-dependent Read more at the source #DrGPCR #GPCR #IndustryNews

bioinformatics are powerful tools to build modular, reproducible, and reusable pipelines for computer-aided drug

underlying non-alcoholic fatty liver disease (NAFLD) have yet to be fully delineated and only a single drug Signaling 7 (RGS7) in hyperlipidemia-dependent hepatic dysfunction. " Read more at the source #DrGPCR #GPCR

August 2022 "Abstract Sigma receptor is a transmembrane non-GPCR protein expressed mainly in the endoplasmic In this study, we report the discovery of a novel lead compound for S1R binding, based on the thiazolidine Read more at the source #DrGPCR #GPCR #IndustryNews

In this review, we focus on recent advances in G-protein-coupled receptor (GPCR) targets. receptor-4 (MC4R), adhesion, lysophosphatidic acid (LPA) and smoothened (Smo) receptors to initiate new drug-screening

introduced Basecamp Bio, a wholly owned subsidiary dedicated to fueling ShouTi’s pipeline and pursuing drug discovery partnerships." Read more at the source #DrGPCR #GPCR #IndustryNews

August 2022 "Join Us in Boston for Discovery On Target 2022! Discovery on Target (DOT) highlights advances in current and emerging “hot” targets and technologies, as well as target validation strategies for the discovery and development of novel therapeutic agents Read more at the source #DrGPCR #GPCR #IndustryNews

Three G-protein coupled receptors (GPCRs) for galanin have been discovered, which is the focus of efforts To understand the basis of the ligand preferences of the receptors and to assist structure-based drug Read more at the source #DrGPCR #GPCR #IndustryNews

Recently, many novel discoveries have underlined the regulatory roles of neurotransmitters in the microenvironment neurotransmitters in the normal neural and the GBM microenvironments, and discuss potential targeted drugs Read more at the source #DrGPCR #GPCR #IndustryNews

demonstrate that the chemoreceptor genes, srg-36 and srg-37, which encode G protein-coupled receptors (GPCRs Here, we show that SRG-36 and SRG-37 act as upstream GPCRs that activate EGL-30. SRG-36 and SRG-37 are GPCRs for the dauer-inducing ascaroside, ascr#5. Thus, ascaroside signaling promotes axon regeneration by activating the GPCR-Gqα pathway.

ADXN, Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, announced today that it will issue its full-year 2021 financial results on Tim Dyer, CEO, Roger Mills, CMO and Robert Lütjens, Head of Discovery Biology, will provide a business media at 16:00 CET (15:00 GMT / 10:00 EST / 07:00 PST) the same day. " Read more at the source #DrGPCR #GPCR

Pathways "Adhesion G protein-coupled receptor A1 (ADGRA1) belongs to the G protein-coupled receptor (GPCR pathways in amygdalae of male mice, implicating a potential, therapeutic application in novel anti-anxiety drug Read more at the source #DrGPCR #GPCR #IndustryNews

Therefore, the identification of such modulators as drug candidates is highly desirable. In this review, we aim to provide an overview of the recent progress in the discovery of biased modulators The challenges and methods for the discovery of TLR4 biased modulators are also outlined. The discovery of biased modulators of TLR4 would provide insight for the future development of biased modulators for other non-GPCR receptors.

In his collaboration with David Hodson, every major leap—from early ligand design to GPCR visualization Throughout his own journey—from organic chemistry to chemical biology to GPCR imaging—every pivotal step  🎧 Listen to the full episode https://www.ecosystem.drgpcr.com/dr-gpcr-podcast/chemical-probes-for-gpcr-imaging-and-internalization

SIX and Nasdaq: ADXN), a clinical-stage pharmaceutical company pioneering allosteric modulation-based drug discovery and development, today announced that its collaboration agreement with Indivior PLC (LON: developing novel oral gamma-aminobutyric acid subtype B (GABAB) positive allosteric modulator (PAM) drug compounds for Charcot-Marie-Tooth type 1A neuropathy (CMT1A) and pain. " Read more at the source #DrGPCR #GPCR

Combination index was analyzed for the combination of fentanyl and chemotherapeutic drugs. Read more at the source #DrGPCR #GPCR #IndustryNews

systems pharmacology (QSP) modeling is an emerging mechanistic computational approach that couples drug It has begun to play important roles in drug development for complex diseases such as cancer, including Read more at the source #DrGPCR #GPCR #IndustryNews

These can be used either as stand-alone therapeutics or to improve the safety profile of opioid drugs electrophysiological recordings to evaluate the effects of YM-254890 on the excitability of dorsal root ganglion (DRG Read more at the source #DrGPCR #GPCR #IndustryNews

December 2022 Sosei Heptares Enters Antibody Discovery Agreement with Twist Bioscience to Discover and Develop Novel Therapeutic Antibodies against GPCR Targets "Collaboration aims to combine Twist’s proprietary world-leading StaR® (stabilized receptor) platform to generate novel antibody leads to disease-relevant GPCR structure-based drug design (SBDD) and development, and Twist Bioscience Corporation (Nasdaq: TWST), Read more at the source #DrGPCR #GPCR #IndustryNews